Demons of Tune Jam House fundraiser raises £5,550 for Cure Leukaemia

20th April 2022


Last week on 13th April 2022, The Demons of Tune reunited for an evening spent at the iconic Jam House in Birmingham to help raise vital funds for Cure Leukaemia. 
 
The evening was kindly sponsored by ClearWater, and saw midland-based cover band The Demons of Tune reunited after 10 years to raise vital funds for Cure Leukaemia, and were supported by duo G&Tomic, featuring Georgia Bray who recently appeared on the BBC's The Voice, where she made it through to the knockout stages. 
 
The evening raised a grand total of £5,550 for Cure Leukaemia, which will make go a long way to helping fund trial programs to help more people. 

Cure Leukeamia supports research nurses within a network of 12 blood cancer centres across the United Kingdom, which form the Trials Acceleration Programme (TAP). 

The TAP network allows the rapid assessment of highly promising and pioneering new treatments for blood cancer through clinical trials. These clinical trials can only run and give patients potentially life-saving options thanks to the positions Cure Leukaemia are funding at these centres. 

 
On the night, Professor Charlie Craddock thanked everyone who attended, and said:  

“We have so much more to do, but we’ve proven above all, we are getting recognized nationally and internationally as putting patients first, and connecting them with white-hot technology, so that lives are transformed and saved, and we remove this blot of blood cancer.

Because of you we are doing magical things, I want you to be so proud of everything you’ve done."


A huge thank you to everyone who brought tickets and attended, and a special thank you to ClearWater for kindly sponsoring the event, along with Tim Clay and everyone else from The Demons of Tune, and everyone at The Jam House.

< Back to List

What we do

The Trials Acceleration Programme (TAP)

How funds raised for Cure Leukaemia help save lives

Cure Leukamia Pre footer image
"Cure Leukaemias funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell
"Cure Leukaemias funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell